We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
-4.48%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.5B
AUM Growth
-$1.68B
Cap. Flow
-$4.46B
Cap. Flow %
-30.76%
Top 10 Hldgs %
17.42%
Holding
749
New
70
Increased
222
Reduced
165
Closed
75

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$66.1M
2
HLT icon
Hilton Worldwide
HLT
+$60.8M
3
ALKS icon
Alkermes
ALKS
+$47.3M
4
APTV icon
Aptiv
APTV
+$47M
5
ABBV icon
AbbVie
ABBV
+$44.8M

Sector Composition

Rank Sector Weight
1 Technology 11.41%
2 Healthcare 10.86%
3 Financials 8.97%
4 Consumer Discretionary 8.6%
5 Industrials 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCUC
51
DELISTED
Dominion Energy, Inc.
DCUC
$60.5M 0.42%
1,219,201
+1,255
+0.1% +$62.7K
FBIN icon
52
Fortune Brands Innovations
FBIN
$6.12B
$60.1M 0.41%
1,482,174
-9,409
-0.6% -$388K
ACHC icon
53
Acadia Healthcare
ACHC
$3.17B
$59.4M 0.41%
895,641
+11,700
+1% +$900K
HCA icon
54
HCA Healthcare
HCA
$84.8B
$57.7M 0.4%
+746,298
New +$66.1M
FCAM
55
DELISTED
Fiat Chrysler Automobiles N.V.
FCAM
$57.4M 0.4%
483,417
+218,429
+82% +$28M
CVX icon
56
Chevron
CVX
$388B
$54.8M 0.38%
694,413
-2,096
-0.3% -$176K
GILD icon
57
Gilead Sciences
GILD
$161B
$54.2M 0.37%
552,389
+267
+0% +$29.7K
HLT icon
58
Hilton Worldwide
HLT
$74B
$54.2M 0.37%
+787,038
New +$60.8M
SPY icon
59
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$54M 0.37%
281,540
-1,351
-0.5% -$274K
CRM icon
60
Salesforce
CRM
$134B
$53.8M 0.37%
774,411
+91,893
+13% +$6.51M
PVH icon
61
PVH
PVH
$3.71B
$53.3M 0.37%
522,639
+77,573
+17% +$8.82M
SWU
62
DELISTED
STANLEY BLACK & DECKER INC CORP UNIT
SWU
$52.8M 0.36%
393,517
-1,745
-0.4% -$246K
APTV icon
63
Aptiv
APTV
$12B
$52.1M 0.36%
684,563
+611,489
+837% +$47M
ALXN
64
DELISTED
Alexion Pharmaceuticals
ALXN
$51.6M 0.36%
329,734
+226,350
+219% +$41.3M
SABR icon
65
Sabre
SABR
$656M
$50.4M 0.35%
1,854,150
-294,592
-14% -$7.97M
HOUS
66
DELISTED
Anywhere Real Estate
HOUS
$50.3M 0.35%
1,337,953
+258,845
+24% +$11.3M
ABBV icon
67
AbbVie
ABBV
$458B
$50M 0.34%
919,018
+688,784
+299% +$44.8M
PEP icon
68
PepsiCo
PEP
$186B
$47.4M 0.33%
502,663
+37
+0% +$3.52K
RCL icon
69
Royal Caribbean
RCL
$78.7B
$46.6M 0.32%
523,340
+96,705
+23% +$8.49M
BAC.PRL icon
70
Bank of America Series L
BAC.PRL
$3.95B
$46.5M 0.32%
43,184
+857
+2% +$948K
RTX icon
71
RTX Corp
RTX
$287B
$46.5M 0.32%
830,211
+45,256
+6% +$2.79M
MET icon
72
MetLife
MET
$61B
$46.3M 0.32%
1,101,770
-540
-0% -$25.2K
T icon
73
AT&T
T
$165B
$46.1M 0.32%
1,873,486
+230,749
+14% +$5.88M
STT icon
74
State Street
STT
$50.9B
$45.5M 0.31%
677,672
+265
+0% +$19.7K
WDC icon
75
Western Digital
WDC
$179B
$45.5M 0.31%
757,232
+50,358
+7% +$3.03M

Similar funds

Calamos Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, Calamos Advisors held 749 positions worth $14.5B, down 10% from $16.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Calamos Advisors withdrew a net $4.46B in Q3 2015, closing 75 positions and reducing 165 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $280M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Calamos Advisors opened a new position in HCA Healthcare worth $57.7M.

  • Calamos Advisors's largest Q3 2015 buy was HCA Healthcare: 746,298 shares worth $57.7M.
  • Calamos Advisors added most to Alkermes in Q3 2015, an estimated $47.3M increase.
  • Calamos Advisors's biggest Q3 2015 reduction was Apple, cutting an estimated $144M.
  • Calamos Advisors fully exited Alphabet (Google) Class C in Q3 2015, selling an estimated $280M.
  • Calamos Advisors's ten largest holdings make up 17% of its $14.5B portfolio in Q3 2015.
  • Calamos Advisors opened 70 new positions and closed 75 in Q3 2015.
  • Calamos Advisors's portfolio value fell 10% quarter-over-quarter to $14.5B.

Based on Calamos Advisors's 13F filing for Q3 2015, filed 10 Nov 2015.